Crossmark

Cost-utility analysis of a web-based interactive patient education platform: evidence from a randomized clinical trial for end-stage renal disease patients

Crossref DOI link: https://doi.org/10.1007/s10198-025-01828-w

Published Online: 2025-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Diop, Modou https://orcid.org/0000-0003-0934-4005
Perrier, Lionel

Haon, Baptiste

Rochaix, Lise

Behaghel, Luc

Dupont, Jean-Claude K.

Morelle, Magali

Elias, Michelle

Esposito, Laure

Legendre, Christophe

Longuet, Hélène

Durand-Zaleski, Isabelle

Pillebout, Evangéline

,

Barrou, Benoit

Boffa, Jean-Jacques

Delbello, Arnaud

Flahaut, Gauthier

Giral, Magali

Gourraud-Vercel, Caroline

Grall-Jezequel, Anne

Houzet-Meurette, Aurélie

Kamar, Nassim

Le Meur, Yannick

Petit-Hoang, Camille

Thervet, Eric

Tricot, Leïla
Funding

Funding for this research was provided by:

Assistance Publique - Hôpitaux de Paris (IC150643)
License Information

Text and Data Mining valid from 2025-09-25

Version of Record valid from 2025-09-25
More Information

Article History

Received: 17 April 2024

Accepted: 4 August 2025

First Online: 25 September 2025

Declarations

:

: Benoit BARROU, Jean-Jacques BOFFA, Arnaud DELBELLO, Michelle ELIAS, Laure ESPOSITO, Gauthier FLAHAUT, Magali GIRAL, Caroline GOURRAUD-VERCEL, Anne GRALL-JEZEQUEL, Aurélie HOUZET-MEURETTE, Nassim KAMAR, Christophe LEGENDRE, Yannick LE MEUR, Hélène LONGUET, Camille PETIT-HOANG, Eric THERVET, Leïla TRICOT.

: There are no conflicts of interest to report.

Document is current

Any future updates will be listed below